The present invention relates to novel 1,3-dihydroindol-2-one (oxindole) derivatives of the formula (I)
in which
A, R
3
, R
4
, R
5
, R
6
and R
7
are defined according to claim
1
, and to medicaments containing them for the treatment of diseases. In particular, the novel oxindole derivaties can be used for the control and/or prophylaxis of various vasopressin-dependent or oxytocin-dependent diseases.
本发明涉及一种新型的1,3-二氢
吲哚-2-酮(氧化
吲哚)衍
生物,其
化学式为(I),其中A、R3、R4、R5、R6和R7根据权利要求1所定义,并且含有它们的药物可用于治疗疾病。特别地,这些新型的氧化
吲哚衍
生物可用于控制和/或预防各种依赖于
加压素或
催产素的疾病。